Meritas Media Team
Erytech Pharma shares are trading higher after the company on Monday announced it secured a U.S. patent titled ‘Method of treating a mammal, including human, against cancer using methionine and asparagine depletion.’
by | Nov 30, 2021 | Uncategorized | 0 comments

Recent Comments